Literature DB >> 7618323

Hepatotoxic reaction to chloroquine phosphate in a patient with previously unrecognized porphyria cutanea tarda.

A C Liu1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7618323      PMCID： PMC1022841     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  17 in total

1.  Acute porphyria and coproporphyrinuria following chloroquine therapy; a report of two cases.

Authors:  M J DAVIS; D E V PLOEG
Journal:  AMA Arch Derm       Date:  1957-06

2.  Development of porphyria during chloroquine therapy for chronic discoid lupus erythematosus.

Authors:  I H LINDEN; C G STEFFEN; V D NEWCOMER; M CHAPMAN
Journal:  Calif Med       Date:  1954-09

3.  The molecular basis of the action of chloroquine in porphyria cutanea tarda.

Authors:  P L Scholnick; J Epstein; H S Marver
Journal:  J Invest Dermatol       Date:  1973-10       Impact factor: 8.551

4.  [Death following administration of 1,250 mg chloroquine in porphyria cutanea tarda].

Authors:  G Drasch; W Eisenmenger
Journal:  Z Rechtsmed       Date:  1986

5.  Porphyria, pseudoporphyria, pseudopseudoporphyria...?

Authors:  M B Poh-Fitzpatrick
Journal:  Arch Dermatol       Date:  1986-04

6.  When the urine is red.

Authors:  L B Berman
Journal:  JAMA       Date:  1977-06-20       Impact factor: 56.272

7.  Porphyria and pseudoporphyria.

Authors:  L C Harber; D R Bickers
Journal:  J Invest Dermatol       Date:  1984-03       Impact factor: 8.551

Review 8.  The cutaneous porphyrias.

Authors:  G H Elder
Journal:  Semin Dermatol       Date:  1990-03

9.  Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda.

Authors:  B F Felsher; A G Redeker
Journal:  Medicine (Baltimore)       Date:  1966-11       Impact factor: 1.889

10.  Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.

Authors:  S Fargion; A Piperno; M D Cappellini; M Sampietro; A L Fracanzani; R Romano; R Caldarelli; R Marcelli; L Vecchi; G Fiorelli
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425
View more
  3 in total

1.  Concurrent Inflammation Augments Antimalarial Drugs-Induced Liver Injury in Rats.

Authors:  Hossein Niknahad; Reza Heidari; Roya Firuzi; Farzaneh Abazari; Maral Ramezani; Negar Azarpira; Massood Hosseinzadeh; Asma Najibi; Arastoo Saeedi
Journal:  Adv Pharm Bull       Date:  2016-12-22

Review 2.  Safety of Short-Term Treatments with Oral Chloroquine and Hydroxychloroquine in Patients with and without COVID-19: A Systematic Review.

Authors:  Sergio Marin; Alba Martin Val; Maite Bosch Peligero; Cristina Rodríguez-Bernuz; Ariadna Pérez-Ricart; Laia Vilaró Jaques; Roger Paredes; Josep Roca; Carles Quiñones
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-21

3.  Protective effect of quercetin on chloroquine-induced oxidative stress and hepatotoxicity in mice.

Authors:  Shrawan Kumar Mishra; Prabhat Singh; Srikanta Kumar Rath
Journal:  Malar Res Treat       Date:  2013-03-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.